In the current study, no significant differences in prognosis were seen between the serum AFP level subgroups, although a very low serum AFP level is well established as a poor prognostic factor in patients with hepatoblastoma [4,15,16,20]. The gene discussed is AFP; the disease is hepatoblastoma.